Large pharmaceutical companies, each with at least $20 billion in 2025 revenue, collectively reduced their workforces by more ...
Two of the world’s largest pharmaceutical companies sued Washington state on Wednesday, alleging a new law to tamp down ...
Takeda is setting the stage for a sweeping new round of restructuring, aiming to streamline operations to bankroll upcoming ...
The trouble for employers centers on a group of drugs typically needed by about 2% of the plan members, but that accounts for ...
The pharmaceutical industry is navigating one of its most disruptive periods in recent memory, according to Anthony Lakavage, ...
Takeda Pharmaceutical Co. expects to book about ¥150 billion ($945 million) in restructuring charges for the fiscal year ...
Hosted on MSN
Pharma R&D set to endure despite rising MFN costs
Pharmaceutical research and development (R&D) is unlikely to be significantly impacted by most favored nation (MFN) pricing, according to industry experts. The US bears the highest drug costs globally ...
Elaine Chen covers biotech, co-writes The Readout newsletter, and co-hosts STAT’s weekly biotech podcast, The Readout Loud. You can reach Elaine on Signal at elaineywchen.70. Among the demands that ...
Ozempic patent expiry has triggered a fresh pharma race in India. Sun Pharma, Cipla, and Dr Reddy’s are among 7 players ...
Nivedha Sampath optimizes pharmaceutical cloud infrastructure, cutting costs by 40% and ensuring multi-regional compliance ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results